Company Overview

Update
Founded:
2008
Founders:
David Rabuka
Headquarters:
Burlingame, CA
Funding:
$11.90M
Categories:
Biotechnology

Redwood Bioscience uses precision protein-chemical engineering to develop optimized and novel biotherapeutics.

Description

Update

Redwood Bioscience is utilizing precision protein-chemical engineering to develop optimized and novel biotherapeutics. The Company's site specific modification technology overcomes the significant challenges associated with conjugating biologics to synthetic molecules to create homogenous hybrid biotherapeutics. Hybrid drugs offer advantages over single agents by providing the specificity and half-life benefits of biologics with the potency benefits of synthetic peptides and small molecules. Leveraging site specifically modified carrier scaffolds, Redwood is developing peptide therapeutics with improved serum half lives and antibody drug conjugates designed to have improved potency and reduced toxicity. Moreover, through “expanding the chemical space of protein drugs”, Redwood is developing heterofunctional products with unique protein-chemical architectures.

The Company is working with partners to enhance the... See More

Current Team (3)

Update

Funding Rounds (5) - $11.90M

Update

Investors (2)

Update
  • D528595fec293143be89ec7d897eec3d

    Mission Bay Capital

    Mission Bay Capital, LLC, is an independent seed-stage venture firm focused on making pivotal,..
  • 19654d6ce2b23ad2a772e43dae8ce5bf

    Takeda Ventures

    TVI's mission is to identify, help create and support the development of therapeutic..

Offices/Locations (1)

Update
  • Office

    863 Mitten Rd

    Suite 101

    Burlingame, CA 94010

    USA